People and Business News – 5/23
The latest people and business news from the past month, all in one place.
People News
Parexel announced the addition of Dr. Scott Smith as SVP, global therapeutic area head of hematology. Prior to joining Parexel, he held several positions at Loyola Medicine's Cardinal Bernardin Cancer Center.
The Almac Group announced the appointment of Ramees Raja as global energy manager. Previously, he spent the previous two years as energy manager for Muntons Pic.
Oracle announced that Seema Verma has been named senior vice president and general manager, life sciences. Most recently, she served as a senior advisor to private equity firms Cressy & Co. and TPG.
Science 37 revealed that they have hired Erica Prowisor as SVP, patient and provider networks. Before this, she spent time as the global head of recruitment and retention for IQUVIA.
American Clinical Research Services appointed Dustin Owen as the new CEO. Previously, Mr. Owen worked at Thermo Fisher Scientific/PPD, where he was SVP and general manager of accelerated enrollment solutions.
Velocity Clinical Research announced the hiring of three executives. Nick Campbell joins as chief commercial officer, Nick Spittal as chief operating officer, and Steph Anderson has been promoted to chief of staff.
ArisGlobal announced the appointment of Julie Springer as the company’s first chief marketing officer. Julie joins ArisGlobal following tenures as CMO at Fast Radius as well as at TransUnion, where she helped lead the company on a significant transformation journey and highly successful IPO.
uMotiff named SAFIRA Clinical Research Co-founder and clinical trial technology innovator Willie Muehlhausen Scientific Advisor, offering 20 years of experience.
Business News
Elligo Health Research opened a new clinical research center in Austin, TX. According to the company, this new center is three times larger than the original location at their headquarters.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Managing Side Effects and Dosing in Off-Label GLP-1 Use with Help from Real-World Evidence
July 18th 2025Shipra Patel, global therapeutic area section head, endocrinology, global head, pediatrics, Parexel, explains how real-world data is helping researchers navigate gastrointestinal side effects, dose flexibility, and long-term tolerability in off-label GLP-1 use.
Anselamimab Misses Primary Endpoint in Phase III CARES Trials for AL Amyloidosis
July 17th 2025In the Phase III CARES trials, anselamimab did not meet the primary endpoint for advanced-stage AL amyloidosis, but a prespecified subgroup analysis revealed meaningful improvements in survival and cardiovascular outcomes.
